3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
3
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Hereditary Sensory and Autonomic Neuropathies
1
Disease Progression
1
Cholangiocarcinoma
1
Bile Duct Neoplasms
1
Interventions
Specimen Handling
9
Magnetic Resonance Spectroscopy
8
Biopsy
8
pembrolizumab
6
Cyclophosphamide
6
X-Rays
5
Phantoms, Imaging
5
Doxorubicin
5
Nuclear Medicine Department, Hospital
4
fludarabine
3
Radiation
3
Irinotecan
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
palbociclib
2
liposomal doxorubicin
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
atezolizumab
2
anlotinib
2
Temozolomide
2
Surveys and Questionnaires
2
Radiotherapy
2
Ifosfamide
2
Gemcitabine
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
tivozanib
×
30 days
×
Clear all
No trials found.